While the ATPase domain of these subunits is essential for tumor cell proliferation and has been targeted with small molecular anticancer agents [15,16], the BRD of BRG1 apparently is dispensable for cell proliferation and is far less studied as a drug target [17]. Here, SMARCA4 is linked to neoplasm.